Evaluation of tumor immune biomarkers with pathologic complete response (pCR) in patients receiving atezolizumab + chemotherapy in early triple negative breast cancer (eTNBC): Exploratory analyses from the IMpassion031 study Meeting Abstract
| Authors: | Molinero, L. L.; Mittendorf, E. A.; Zhang, H.; Barrios, C. H.; Saji, S.; Jung, K. H.; Patel, S.; Chang, C. W.; Liste-Hermoso, M.; Chui, S. Y.; Harbeck, N. |
| Abstract Title: | Evaluation of tumor immune biomarkers with pathologic complete response (pCR) in patients receiving atezolizumab + chemotherapy in early triple negative breast cancer (eTNBC): Exploratory analyses from the IMpassion031 study |
| Meeting Title: | 112th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 81 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2021 Apr 10-15/May 17-21 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2021-07-01 |
| Language: | English |
| ACCESSION: | WOS:000680263501195 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.AM2021-LB162 |
| Notes: | Meeting Abstract: LB162 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos |
